Income Statement

v3.24.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)        
Revenue $ 21,827,827 $ 26,741,562 $ 49,175,469 $ 37,960,361
Cost of Revenue 13,556,574 16,655,117 32,196,367 22,056,433
Gross profit 8,271,253 10,086,445 16,979,102 15,903,928
Operating expenses        
Sales and marketing 2,691,368 3,297,144 5,540,035 5,024,613
Distribution costs 3,247,554 3,575,545 6,098,170 6,063,379
General and administrative expenses 2,303,220 2,517,651 4,559,148 4,645,497
Share-based compensation 330,584 1,052,847 752,471 1,980,173
Amortization of acquired intangible assets 1,157,029 1,102,756 2,343,850 1,832,665
Depreciation 328,619 240,958 614,703 435,455
Total Operating expenses 10,058,374 11,786,901 19,908,377 19,981,782
Loss from operations (1,787,121) (1,700,456) (2,929,275) (4,077,854)
Other income (expense), net        
Change in derivative liability 0 (3,540) 0 (1,770)
Interest (expense) income, net (1,077,084) (1,789,299) (1,951,269) (2,222,777)
Other income (expense), net (1,077,084) (1,792,839) (1,951,269) (2,224,547)
Income (loss) on operations before income tax (2,864,205) (3,493,295) (4,880,544) (6,302,401)
Gain on sale of Infusionz and select assets 0 7,564,363 0 7,564,363
Gain (loss) from the sale of Interactive Offers (39,691) 0 340,933  
Lease settlement, California facility 61,138 0 61,138  
Lease impairment, Delray Beach facility (289,968) 0 (289,968)  
(Loss) income from discontinued operations 0      
Income tax benefit (expense) 694,807 (755,253) 1,167,174 (47,052)
Net income (loss) from continuing operations (2,437,919) 3,315,815 (3,601,267) 1,214,910
(Loss) income from discontinued operations 0 (731,717) (193,040) (1,376,332)
Net loss attributable to non-controlling interest 0 85,581 0 233,586
Net income (loss) attributable to Upexi, Inc. $ (2,437,919) $ 2,669,679 $ (3,794,307) $ 72,164
Basic income (loss) per share:        
Income (loss) per share from continuing operations $ (0.12) $ 0.19 $ (0.19) $ 0.08
(Loss) income per share from discontinued operations 0 (0.04) (0.01) (0.08)
Total income (loss) per share (0.12) 0.15 (0.18) 0.00
Diluted income (loss) per share:        
Income (loss) per share from continuing operations (0.12) 0.17 (0.18) 0.07
(Loss) income per share from discontinued operations 0 (0.3) 0 (0.07)
Total income (loss) per share $ (0.12) $ 0.14 $ (0.18) $ 0.07
Basic weighted average shares outstanding 20,306,871 17,540,427 20,275,745 15,452,453
Fully diluted weighted average shares outstanding 20,306,871 19,030,705 20,275,745 17,220,564

Source